Mechanisms of age-related macular degeneration

Ophthalmology Clinics of North America

Volumn 15, Issue 1, 2002, Pages 87-91

  Husain, Deeba ^a   Ambati, Balamurali ^a   Adamis, Anthony P ^a   Miller, Joan W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; VASCULOTROPIN;

ANGIOGENESIS; ATHEROSCLEROSIS; ATROPHY; CIGARETTE SMOKING; DEGENERATIVE DISEASE; EPIDEMIOLOGICAL DATA; FIBROSIS; HEREDITY; HUMAN; NONHUMAN; NUTRITION; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; REVIEW; RISK FACTOR; SCAR; SUBRETINAL NEOVASCULARIZATION; VISUAL IMPAIRMENT; METABOLISM; RETINA MACULA DEGENERATION;

HUMANS; MACULAR DEGENERATION;

EID: 0036014911     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(01)00009-8     Document Type: Article

References (44)

1. Inhibition of VEGF prevents retinal ischemia-associated iris neo-vascularization in a nonhuman primate
2. VEGF in ocular fluid of patients with diabetic retinopathy and other retinal disorders
3. Suppression of retinal neovascularization in vivo by inhibition of VEGF using soluble VEGF-receptor chimeric proteins
4. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration
5. Therapeutic and prophylactic effect of a recombinant human binding fragment of a monoclonal antibody directed to vascular endothelial growth factor (RHUFAB) in a monkey model of laser induced choroidal neovascularization
6. Choroidal neovascularization in the rat induced by adenovirus mediated statement of vascular endothelial growth factor
7. Role of oxidative stress in the pathogenesis of age-related macular degeneration
8. The effect of cigarette smoking on the intraocular circulation
9. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities
10. Reactive oxygen species and antioxidant vitamins: Mechanism of action
11. Age related macular degeneration
12. avb3, avb5, and osteopontin immunostaining in experimental choroidal neovascularization in the monkey
13. Statement of integrens avb3 and avb5 in human choroidal neovascular membranes
14. The role of the Atherosclerotic process in the pathogenesis of age-related macular degeneration
15. Foveolar choroidal blood flow in age-related macular degeneration
16. Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: A role of VEGF and possible treatment for SRN in age-related macular degeneration
17. The Framingham eye study. Outline and major prevalence findings
18. Epidemiology
19. The five-year incidence and progression of age-related maculopathy: The Beaver Dam eye study
20. Prevalence of age-related maculopathy: The Beaver Dam Eye study
21. Mechanism of action of biological antioxidants
22. VEGF is major stimulator in model of choroidal neovascularization
23. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes
24. Natural history
25. VEGF is temporally and spatially correlated with ocular angiogenesis in a primate model
26. Prevalence of age-related maculopathy in Australia: The Blue mountain eye study
27. Pulsatile ocular blood flow study: Decreases in exudative age-related macular degeneration
28. A twin study of age-related macular degeneration
29. Effect of caretenoid depletion and N-3 fatty acid status on macular defects in rhesus monkeys
30. Immunolocalization of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule (VCAM-1) in choroidal neovascularization in human
31. Transgenic mice with increased statement of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization
32. Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes
33. The radical in cigarette tar: Their nature and suggested physiological implications
34. Foveal electro-etinograms and choroidal perfusion characteristics in fellow eyes of patients with unilateral neovascular age-related macular degeneration
35. A role of pigment epithelial derived growth factor in choroidal neovascular membrane development
36. Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age-related macular degeneration
37. Familial aggregation of age-related maculopathy
38. Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor
39. Gender, oestrogen, hormone replacement and age related macular degeneration: Results from the Blue mountains eye study
40. Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration
41. The 4 alleles of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration
42. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model
43. Intravitreous injections of VEGF produce retinal ischemia and microangiopathy in an adult primate
44. The prevalence of age-related macolopathy in the Rotterdam study